[BEAT] BioTelemetry, Inc.


Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 23 Change: -0.35 (-1.5%)
Ext. hours: Change: 0 (0%)

chart BEAT

Refresh chart

Strongest Trends Summary For BEAT

BEAT is in the medium-term down -12% in 2 months and down -21% in 5 months and down -49% below S&P in 1 year. In the long-term up 1113% in 11 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devi

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1.84% Sales Growth - Q/Q-0.5% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-4.9% ROE-8.96% ROI
Current Ratio1.54 Quick Ratio1.43 Long Term Debt/Equity1.56 Debt Ratio0.43
Gross Margin56.14% Operating Margin-0.09% Net Profit Margin-3.32% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-1.04 M Cash From Operating Activities-2.07 M Gross Profit25.22 M
Net Profit-4.61 M Operating Profit470 K Total Assets117.16 M Total Current Assets42.32 M
Total Current Liabilities27.54 M Total Debt23.11 M Total Liabilities53.11 M Total Revenue43.44 M
Technical Data
High 52 week77.59 Low 52 week41.92 Last close41.99 Last change-1.73%
RSI39.23 Average true range2.13 Beta0.77 Volume232.81 K
Simple moving average 20 days-6.41% Simple moving average 50 days-11.19% Simple moving average 200 days-28.37%
Performance Data
Performance Week-0.1% Performance Month-12.54% Performance Quart-17.05% Performance Half-43.24%
Performance Year-27.42% Performance Year-to-date-29.69% Volatility daily2.43% Volatility weekly5.43%
Volatility monthly11.12% Volatility yearly38.52% Relative Volume858.67% Average Volume405.31 K
New High New Low


2019-11-11 18:40:49 | Edited Transcript of BEAT earnings conference call or presentation 5-Nov-19 10:00pm GMT

2019-11-11 13:12:10 | Mario Gabelli Continues to Buy AbbVie, Axalta

2019-11-05 19:05:12 | BioTelemetry BEAT Beats Q3 Earnings and Revenue Estimates

2019-11-05 16:05:00 | BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

2019-11-02 09:19:10 | If You Had Bought BioTelemetry NASDAQ:BEAT Shares Five Years Ago You'd Have Made 414%

2019-10-29 14:54:57 | BioTelemetry, Inc. to Release Third Quarter 2019 Earnings Results on November 5, 2019

2019-10-28 09:13:33 | Were Hedge Funds Right About Dumping BioTelemetry, Inc. BEAT?

2019-10-07 08:07:37 | What Does BioTelemetry, Inc.'s NASDAQ:BEAT Share Price Indicate?

2019-09-10 14:30:38 | Is BioTelemetry, Inc.'s NASDAQ:BEAT Capital Allocation Ability Worth Your Time?

2019-09-03 16:05:00 | BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List

2019-08-15 12:44:20 | BioTelemetry NASDAQ:BEAT Has A Pretty Healthy Balance Sheet

2019-08-05 12:07:32 | BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer

2019-07-31 10:16:15 | Edited Transcript of BEAT earnings conference call or presentation 30-Jul-19 9:00pm GMT

2019-07-30 22:24:32 | BioTelemetry Inc BEAT Q2 2019 Earnings Call Transcript

2019-07-30 20:05:12 | BioTelemetry BEAT Q2 Earnings and Revenues Beat Estimates

2019-07-30 16:05:00 | BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results

2019-07-24 08:30:00 | BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB and Expands International Service Offering

2019-07-23 10:32:02 | Analysts Estimate BioTelemetry BEAT to Report a Decline in Earnings: What to Look Out for

2019-07-19 17:58:57 | BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019

2019-07-18 09:58:01 | BioTelemetry BEAT to Report Q2 Earnings: What's in Store?

2019-07-17 10:32:02 | Analysts Estimate BioTelemetry BEAT to Report a Decline in Earnings: What to Look Out for

2019-07-16 14:24:08 | Does BioTelemetry, Inc.'s NASDAQ:BEAT CEO Salary Compare Well With Others?

2019-06-13 07:07:20 | With A Return On Equity Of 15%, Has BioTelemetry, Inc.'s NASDAQ:BEAT Management Done Well?

2019-06-04 07:30:00 | Itamar Medical and BioTel Heart, a Division of BioTelemetry, Expand Collaboration to Offer Itamar’s Total Sleep Solution™ to BioTel Heart Cardiology Customers

2019-05-30 17:50:09 | BioTelemetry BEAT Outpaces Stock Market Gains: What You Should Know

2019-05-25 09:15:01 | Gap Up to Get Down

2019-05-17 10:08:46 | Does BioTelemetry, Inc. NASDAQ:BEAT Have A High Beta?

2019-05-15 13:52:52 | BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards

2019-04-30 15:16:54 | Here’s What Hedge Funds Think About BioTelemetry, Inc. BEAT

2019-04-26 08:12:45 | BioTelemetry Inc BEAT Q1 2019 Earnings Call Transcript

2019-04-26 08:02:57 | The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug

2019-04-26 02:12:39 | Edited Transcript of BEAT earnings conference call or presentation 25-Apr-19 9:00pm GMT

2019-04-25 17:26:27 | BioTelemetry: 1Q Earnings Snapshot

2019-04-25 16:05:00 | BioTelemetry, Inc. Reports First Quarter 2019 Financial Results

2019-04-24 07:00:43 | Should You Investigate BioTelemetry, Inc. NASDAQ:BEAT At US$58.57?

2019-04-23 08:49:12 | BioTelemetry BEAT to Report Q1 Earnings: What's in Store?

2019-04-23 05:45:09 | Bull of the Day: BioTelemetry BEAT

2019-04-22 17:52:09 | Top Stock Picks for the Week of Apr 22, 2019

2019-04-18 17:45:09 | BioTelemetry BEAT Outpaces Stock Market Gains: What You Should Know

2019-04-18 13:22:39 | BioTelemetry, Inc. to Release First Quarter 2019 Earnings Results on April 25, 2019

2019-04-17 10:31:02 | BioTelemetry BEAT Earnings Expected to Grow: Should You Buy?

2019-04-12 10:32:02 | Teladoc's Partnership to Form Pediatric Telehealth Platform

2019-04-11 09:15:01 | Old News is Good News

2019-04-08 09:30:01 | Has BioTelemetry BEAT Outpaced Other Medical Stocks This Year?

2019-04-04 17:45:09 | BioTelemetry BEAT Stock Sinks As Market Gains: What You Should Know

2019-04-04 13:25:46 | Why You Should Keep An Eye On These Leading Health Care Stocks

2019-04-01 14:38:57 | BioTelemetry NASDAQ:BEAT Shareholders Have Enjoyed A Whopping 538% Share Price Gain

2019-03-28 17:45:09 | BioTelemetry BEAT Outpaces Stock Market Gains: What You Should Know

2019-03-21 17:45:09 | BioTelemetry BEAT Gains But Lags Market: What You Should Know

2019-03-21 08:16:00 | Dear Apple, Is My Heart OK?